Answers are grounded in this paper and cite their sources.
ObjectivesThis is a protocol for a Cochrane Review (intervention).The objectives are as follows:To assess the comparative e icacy and safety of fixed-dose dual inhalers (i.e.LABA/LAMA versus ICS/LABA) and combination therapies versus LABA or LAMA monotherapy in individuals with moderate to very severe COPD, using network meta-analysis, and to rank these treatments based on their e icacy and safety.
No takes yet. Share an insight, caveat, or question.
Oba et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: